Medmira Stock Odds of Future Pink Sheet Price Finishing Over 0.0574
| MMIRF Stock | USD 0.06 0.00 0.00% |
MedMira |
MedMira Target Price Odds to finish over 0.0574
The tendency of MedMira Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.06 | 90 days | 0.06 | about 23.69 |
Based on a normal probability distribution, the odds of MedMira to move above the current price in 90 days from now is about 23.69 (This MedMira probability density function shows the probability of MedMira Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon MedMira has a beta of -5.67. This indicates as returns on its benchmark rise, returns on holding MedMira are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, MedMira is expected to outperform its benchmark. In addition to that MedMira has an alpha of 5.553, implying that it can generate a 5.55 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). MedMira Price Density |
| Price |
Predictive Modules for MedMira
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MedMira. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.MedMira Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. MedMira is not an exception. The market had few large corrections towards the MedMira's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MedMira, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MedMira within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 5.55 | |
β | Beta against Dow Jones | -5.67 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.12 |
MedMira Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MedMira for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MedMira can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| MedMira is way too risky over 90 days horizon | |
| MedMira has some characteristics of a very speculative penny stock | |
| MedMira appears to be risky and price may revert if volatility continues | |
| MedMira has high likelihood to experience some financial distress in the next 2 years | |
| MedMira has accumulated 40 K in total debt. MedMira has a current ratio of 0.14, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist MedMira until it has trouble settling it off, either with new capital or with free cash flow. So, MedMira's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MedMira sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MedMira to invest in growth at high rates of return. When we think about MedMira's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 952.13 K. Net Loss for the year was (1.83 M) with loss before overhead, payroll, taxes, and interest of (512.51 K). | |
| MedMira has accumulated about 396.14 K in cash with (1.88 M) of positive cash flow from operations. | |
| Roughly 70.0% of the company outstanding shares are owned by corporate insiders |
MedMira Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MedMira Pink Sheet often depends not only on the future outlook of the current and potential MedMira's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MedMira's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 697.4 M |
MedMira Technical Analysis
MedMira's future price can be derived by breaking down and analyzing its technical indicators over time. MedMira Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of MedMira. In general, you should focus on analyzing MedMira Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
MedMira Predictive Forecast Models
MedMira's time-series forecasting models is one of many MedMira's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary MedMira's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about MedMira
Checking the ongoing alerts about MedMira for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for MedMira help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| MedMira is way too risky over 90 days horizon | |
| MedMira has some characteristics of a very speculative penny stock | |
| MedMira appears to be risky and price may revert if volatility continues | |
| MedMira has high likelihood to experience some financial distress in the next 2 years | |
| MedMira has accumulated 40 K in total debt. MedMira has a current ratio of 0.14, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist MedMira until it has trouble settling it off, either with new capital or with free cash flow. So, MedMira's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MedMira sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MedMira to invest in growth at high rates of return. When we think about MedMira's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 952.13 K. Net Loss for the year was (1.83 M) with loss before overhead, payroll, taxes, and interest of (512.51 K). | |
| MedMira has accumulated about 396.14 K in cash with (1.88 M) of positive cash flow from operations. | |
| Roughly 70.0% of the company outstanding shares are owned by corporate insiders |
Other Information on Investing in MedMira Pink Sheet
MedMira financial ratios help investors to determine whether MedMira Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MedMira with respect to the benefits of owning MedMira security.